Best first-line therapy for patients with advanced non-small cell lung cancer, performance status 2 without a targetable mutation or with an unknown mutation status

Rolof G.P. Gijtenbeek*, Kim de Jong, Ben J.W. Venmans, Femke H.M. van Vollenhoven, Anneke Ten Brinke, Anthonie J. Van der Wekken, Wouter H. van Geffen

*Bijbehorende auteur voor dit werk

OnderzoeksoutputAcademicpeer review

Samenvatting

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To identify the best first-line therapy for advanced lung cancer in patients with performance status 2 without a targetable mutation or with an unknown mutation status.

Originele taal-2English
ArtikelnummerCD013382
Aantal pagina's14
TijdschriftCochrane Database of Systematic Reviews
Volume2019
Nummer van het tijdschrift8
DOI's
StatusPublished - 12-aug-2019

Citeer dit